Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nail-S Patch is a topical hydrogel patch containing urea, developed by Wooshin Labottach Co., Ltd. for the treatment of various nail disorders, including nail fragility, onychomycosis (nail fungus), and nail psoriasis. The patch utilizes a specialized delivery system to provide sustained release of urea directly to the nail plate. Urea functions as a keratolytic agent, hydrating and softening the nail by denaturing keratin proteins. This process facilitates the debridement of thickened or diseased nail tissue and may enhance the penetration of other topical therapeutic agents. The product has been evaluated in clinical trials to assess its efficacy in improving nail texture and appearance in patients with chronic nail conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nail-S Patch.